HCG & Weight Loss

In recent years, HCG has become a very popular option for weight loss. Promoters of HCG claim that it can reduce feelings of hunger and support weight loss by redistributing body fat from the thighs, stomach, and hips. The supposed benefits of HCG for weight loss are impressive, but what does the research say?


In the 1950s a British endocrinologist named Albert Simeons was investigating HCG as a treatment for Frohlich’s syndrome, a delayed development of the genitals in adolescent boys caused by a pituitary gland disorder. During his trials he noted that boys treated with HCG had lost weight and had less appetite. This lead to Dr. Simeons turning his research to HCG for weight loss and he created a diet plan that includes the use of HCG in combination with a very low calorie (500 calories per day) diet.

While Dr. Simeons was able to generate interesting results using his protocol, other researchers have failed to replicate them. A meta-analysis that included more than 20 different studies of HCG found that “there is no scientific evidence that HCG is effective in the treatment of obesity; it does not bring about weight-loss of fat-redistribution, nor does it reduce hunger or induce a feeling of well-being” (Lijesen et al, 1995).


It is important to note that HCG has never been approved for use in weight loss. “Currently, there are no FDA-approved HCG drug products for weight loss.  HCG has not been demonstrated to be effective therapy in the treatment of obesity.  There is no substantial evidence that HCG increases weight loss” (FDA, 2016).

After years of warning against the use of HCG for weight loss, the FDA may have found a way to discourage its use. The FDA has recently reclassified HCG as a biological product, an action which has the potential to severely limit access to this medication. You can read our blog about the regulatory change here.

A Natural Alternative

The evidence supporting the use of HCG to encourage fat burning and preserve lean muscle mass is sparse, and the mechanism of action is not well explained. However, there is a molecule which has been extensively studied and proven to provide many of the same benefits claimed by HCG: cAMP. cAMP is normally increased during fasting or exercise, but can also be increased pharmacologically with use of readily available OTC ingredients.

cyclic adenosine monophosphate (cAMP)

Role of cAMP in optimizing body composition

Cyclic adenosine monophosphate (cAMP) is an important messenger for many biological processes including metabolism. cAMP promotes breakdown of stored fats, regulates thermogenic responses to food, increases the body’s metabolic rate, and increases the utilization of fat.

cAMP controls enzymes which are responsible for fat burning. “Typically, an increase in cAMP levels leads to subsequent activation of protein kinase. Protein kinase has been shown to activate the hormone-sensitive lipase that is involved in the breakdown of triglycerides, known as building blocks of fatty tissue”(Berdeaux & Stewart, 2012). Hormone sensitive lipase is essential for providing energy to the cells by mobilizing stored fats through lipolysis.

cAMP signaling is the major positive regulator of lipolysis in adipose tissue. cAMP activation of PKA promotes lipolysis via activation of hormone-sensitive lipase and adipose triglyceride lipase.


Lipolysis is the metabolic pathway in which stored triglycerides are broken down to release fatty acids. This is an important step in fat metabolism, allowing for stored fat to be converted to energy. Without lipolysis, the body has a difficult time accessing these fatty acids and may look for other less desirable sources for creating energy.

“Lipolysis of white adipose tissue triacylglycerol stores results in the liberation of glycerol and nonesterified fatty acids that are released into the vasculature for use by other organs as energy substrates” (Duncan et al, 2007).

Promoting Lean Body Mass

In addition to promoting fat burning, cAMP encourages development of lean muscle. Researchers have demonstrated that “cAMP participates in muscle development and regeneration mediated by muscle precursor cells” (Berdeaux & Stewart, 2012).

Muscle growth is the result of a complex process that adds more myosin “filaments” to each muscle fiber.

In the muscles, increasing cAMP results in increased activity of glycolysis, an ATP-producing process that begins with the breakdown of glucose. Studies have found that low glycolytic activity is associated with reduced muscle size (Tixier et al, 2013). Increasing glycolysis in the muscles provides fuel for the muscles and may help encourage muscle development.

In the liver, cAMP promotes gluconeogenesis, producing glucose from non-carbohydrate sources. This glucose is pumped into the muscles, which have an increased demand due to higher glycolytic activity, and can even have an appetite-sparing effect.

Together these effects result in increased lean body mass, decreased fat mass, and a reduced appetite all from a molecule already found in the human body: cAMP!

Looking for an alternative to HCG? Contact us today!


Schwarcz, J. (2017). The Skinny on the HCG Weight Loss Scheme. McGill University.
Lijesen, G. K., Theeuwen, I., Assendelft, W. J., & Van Der Wal, G. (1995). The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. British journal of clinical pharmacology40(3), 237–243. https://doi.org/10.1111/j.1365-2125.1995.tb05779. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1365103/
FDA. (2016). Questions and Answers on HCG Products for Weight Loss. Retrieved from: https://www.fda.gov/drugs/medication-health-fraud/questions-and-answers-hcg-products-weight-loss
FDA. (2019). Preliminary List of Approved NDAs for Biological Products. Retrieved from: https://www.fda.gov/media/119229/download
Berdeaux, R., & Stewart, R. (2012). cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration. American journal of physiology. Endocrinology and metabolism303(1), E1–E17. https://doi.org/10.1152/ajpendo.00555.2011
Tixier, V., et al. (2013). Glycolysis supports embryonic muscle growth by promoting myoblast fusion. PNAS 110 (47) 18982-18987

Taylor Froiland is the president of Legere Pharmaceuticals in Scottsdale, Arizona and serves on the Board of Directors for RK Logistics Group. He also owns and operates Medmetrics Compounding Pharmacy in Chandler, Arizona, specializing in various pharmaceutical services. Taylor holds a PharmD and has expertise in compounding, medicinal chemistry, and quality control.
Related Posts

Ready to Start Growing Your Practice? Let’s Chat!

To get started, please fill out this quick form and let us know more about your business.